Therapeutic potential of TGF-β inhibition in chronic renal failure

被引：35
|
作者：
Gagliardini, Elena [1 ]
Benigni, Ariela [1 ]
机构：
[1] Mario Negri Inst Pharmaceut Res, I-24125 Bergamo, Italy
来源：
EXPERT OPINION ON BIOLOGICAL THERAPY | 2007年 / 7卷 / 03期
关键词：
progressive nephropathies; proteinuria; renal fibrosis; transforming growth factor-beta;
D O I：
10.1517/14712598.7.3.293
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Chronic kidney diseases are emerging as a worldwide public health problem. The progression of kidney diseases closely correlates with the accumulation of extracellular matrix leading to glomerulosclerosis and tubulointerstitial injury. Transforming growth factor (TGF)-beta has been identified as a key mediator of kidney matrix accumulation. Overexpression of TGF-beta isoforms and their receptors was observed in a variety of renal diseases in both animals and humans. Given its crucial role in fibrotic kidney disease, TGF-beta has been recently considered as a possible target in the management of chronic renal diseases. This review discusses the role of TGF-beta in renal fibrosis and provides an overview of the strategies that, when interfering with TGF-beta expression and signalling, could be employed as new renoprotective treatments.
引用
收藏
页码：293 / 304
页数：12
相关论文
共 50 条
  • [1] Effect of TGF-β1 antisense oligodeoxynucleotide on renal function in chronic renal failure rats
    Hiong, Law Chung
    Voon, Kiew Lik
    Abdullah, Nor Azizan
    Sattar, Munavvar A.
    Rahman, Nazarina Abdul
    Khan, Abdul Hye
    Johns, Edward James
    ACTA PHARMACOLOGICA SINICA, 2008, 29 (04) : 451 - 457
  • [2] Effect of TGF-β1 antisense oligodeoxynucleotide on renal function in chronic renal failure rats
    Law Chung Hiong
    Kiew Lik Voon
    Nor Azizan Abdullah
    Munavvar A Sattar
    Nazarina Abdul Rahman
    Abdul Hye Khan
    Edward James Johns
    Acta Pharmacologica Sinica, 2008, 29 : 451 - 457
  • [3] TGF-β:: Its role in asthma and therapeutic potential
    Howell, JE
    McAnulty, RJ
    CURRENT DRUG TARGETS, 2006, 7 (05) : 547 - 565
  • [4] Genomic damage in chronic renal failure - Potential therapeutic interventions
    Stopper, H
    Schupp, N
    Klassen, A
    Sebekova, K
    Heidland, A
    JOURNAL OF RENAL NUTRITION, 2005, 15 (01) : 81 - 86
  • [5] Immunotherapeutic Potential of TGF-β Inhibition and Oncolytic Viruses
    Groeneveldt, Christianne
    van Hall, Thorbald
    van der Burg, Sjoerd H.
    ten Dijke, Peter
    van Montfoort, Nadine
    TRENDS IN IMMUNOLOGY, 2020, 41 (05) : 406 - 420
  • [6] The TGF-β superfamily as potential therapeutic targets in pancreatic cancer
    Tindall, Rachel R.
    Bailey-Lundberg, Jennifer M.
    Cao, Yanna
    Ko, Tien C.
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [7] Therapeutic potential of active TGF-β1 to ameliorate lethal phenotype of TGF-β1 null mice
    Longenecker, G
    Thyagarajan, T
    Nagineni, CN
    Flanders, K
    Factor, V
    Miller, G
    Ward, JM
    Nalca, A
    Rangnekar, V
    Thorgeirsson, S
    Kulkarni, AB
    MOLECULAR BIOLOGY OF THE CELL, 1999, 10 : 449A - 449A
  • [8] Recent advances in TGF-β effects on chondrocyte metabolism -: Potential therapeutic roles of TGF-β in cartilage disorders
    Grimaud, E
    Heymann, D
    Rédini, F
    CYTOKINE & GROWTH FACTOR REVIEWS, 2002, 13 (03) : 241 - 257
  • [9] Therapeutic potential of renal sympathetic denervation in patients with chronic heart failure
    Boehm, Michael
    Ewen, Sebastian
    Linz, Dominik
    Reil, Jan-C.
    Schirmer, Stephan H.
    Ukena, Christian
    Mahfoud, Felix
    EUROINTERVENTION, 2013, 9 : R122 - R126
  • [10] Association of TGF-β1 polymorphisms with chronic renal disease
    Coll, E
    Cormand, B
    Campos, B
    González-Núñez, D
    Iñigo, P
    Botey, A
    Poch, E
    JOURNAL OF NEPHROLOGY, 2004, 17 (06) : 794 - 799
12345